Carole Dantin

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better.

Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better.

Journal: EJHaem
Published: October 17, 2022

Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.

Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.

Journal: Transplantation and cellular therapy
Published: May 26, 2022

Rhinovirus Infections among Hematopoietic Stem Cell Transplant Recipients: A Pre-Transplant Dilemma?

Rhinovirus Infections among Hematopoietic Stem Cell Transplant Recipients: A Pre-Transplant Dilemma?

Journal: Viruses
Published: December 17, 2021

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.

Journal: Bone marrow transplantation
Published: July 24, 2021

Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation.

Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Frontiers in immunology
Published: December 17, 2019

Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Journal: Bulletin du cancer
Published: October 07, 2019

Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation.

Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation.

Journal: Leukemia
Published: July 02, 2019

How to capture cytogenetic and molecular abnormalities into ProMISe database for hematological malignancies: Guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)

How to capture cytogenetic and molecular abnormalities into ProMISe database for hematological malignancies: Guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)

Journal: Bulletin du cancer
Published: April 09, 2019

Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.

Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Frontiers in immunology
Published: January 20, 2019

Human pegivirus persistence in human blood virome after allogeneic haematopoietic stem-cell transplantation.

Human pegivirus persistence in human blood virome after allogeneic haematopoietic stem-cell transplantation.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 09, 2018

Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome.

Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome.

Journal: Bone marrow transplantation
Published: September 19, 2017

Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation.

Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation.

Journal: Leukemia & lymphoma
Published: July 07, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026